In March 2025, the company introduced new ideas for just a direct-to-buyer presenting of its Wegovy weight loss drug. The company founded a different pharmacy, known as NovoCare, which might charge buyers $499 each month for use of the drug, fewer than fifty percent the price of the drug through other pharmaceutical distribution networks.[53]Novo N